Drug Discovery · Haddonfield, NJ · Founded 2016 · Privately Held (backing)
Developer of molecular therapeutics designed to treat cancer and skin pigmentation disorders. Linnaeus Therapeutics is based in Haddonfield, NJ and was founded in 2016. It was valued at $83.1 million at its later-stage round in Apr 2026, the last priced event on record. It has raised $35.6 million across 8 recorded rounds; the latest was a $5 million seed round in Feb 2026.
PMV mark · valuation
$83.1M
Oct 2026
Priced at
its later-stage round
Apr 2026
Total raised
$35.6M
Last round
Seed Round
Feb 2026
No prints on record
No secondary trades in Linnaeus Therapeutics shares have been recorded yet. When market activity lands it appears here as monthly aggregates and, for platform-recorded trades, dated prints.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Linnaeus Therapeutics with a free account
·Watch Linnaeus Therapeutics: the Monday email on marks, rounds and moves
Secondary marks are indicative month-end price levels observed across secondary-market trading venues — a level, not a trade — and are the market input to the PrivateMarketView mark. Private share prices aren’t published anywhere. Aggregate figures combine multiple reporting channels — direct participant reports, platform transactions, third-party market intelligence — at monthly granularity. Individually dated prints are a Pro feature and are shown only for transactions recorded on our own platform. Third-party-reported trades are never republished individually, at any tier. Verified prints (✓) have been confirmed against a second source. Prints marked SPV or Forward reflect the structure’s pricing, which can differ from direct share transfers of Linnaeus Therapeutics stock.
